Jul 5, 2022 8:30 am EDT Anebulo Pharmaceuticals Announces Positive Topline Data for ANEB-001 from a Phase 2 Clinical Trial for Acute Cannabinoid Intoxication Conference Call and Webcast
Jun 25 – Jun 30, 2022 32nd Annual International Cannabinoid Research Society Symposium on the Cannabinoids
